Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1182

1.

[Renal hypertension--the role of the kidneys in blood pressure regulation and the kidneys as end organ].

Grendelmeier I.

Ther Umsch. 2015 Jun;72(6):369-74. doi: 10.1024/0040-5930/a000688. Review. German.

PMID:
26098186
2.

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GW, Muntner P, Roderick P, Sairenchi T, Schöttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Ärnlöv J; CKD Prognosis Consortium.

Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25. doi: 10.1016/S2213-8587(15)00040-6. Epub 2015 May 28.

PMID:
26028594
3.

ABCG8 polymorphisms and renal disease in type 2 diabetic patients.

Nicolas A, Fatima S, Lamri A, Bellili-Muñoz N, Halimi JM, Saulnier PJ, Hadjadj S, Velho G, Marre M, Roussel R, Fumeron F.

Metabolism. 2015 Jun;64(6):713-9. doi: 10.1016/j.metabol.2015.03.005. Epub 2015 Mar 14.

PMID:
25804128
4.

Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.

Warady BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S.

Am J Kidney Dis. 2015 Jun;65(6):878-88. doi: 10.1053/j.ajkd.2015.01.008. Epub 2015 Mar 19.

PMID:
25799137
5.

Aldosterone blockade in CKD: emphasis on pharmacology.

Schwenk MH, Hirsch JS, Bomback AS.

Adv Chronic Kidney Dis. 2015 Mar;22(2):123-32. doi: 10.1053/j.ackd.2014.08.003. Review.

PMID:
25704349
6.

Laboratory diagnostics of chronic kidney disease in Croatia: state of the art.

Biljak VR, Honović L, Matica J, Knežević B, Vojak SŠ.

Biochem Med (Zagreb). 2015;25(1):73-83. doi: 10.11613/BM.2015.009.

7.

Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study.

Vejakama P, Ingsathit A, Attia J, Thakkinstian A.

Medicine (Baltimore). 2015 Jan;94(4):e475. doi: 10.1097/MD.0000000000000475.

PMID:
25634196
8.

Rituximab as a rescue therapy in patients with glomerulonephritis.

Souqiyyeh MZ, Shaheen FA, Alsuwaida A, Alghonaim M, Alwakeel J, Mosa D, Akhtar F, Rahman E, Husain M, Roujouleh H, Siddiqi N, Bukhari I, Sadaqa N, Mushtaque F, Awn NM, Shariya F, Alfi A, Amin M, Ahmad M, Rowaie FA, Almueilo S, Kechrid MC, Karkar A.

Saudi J Kidney Dis Transpl. 2015 Jan;26(1):47-55.

9.

Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria.

Genctoy G, Arikan S, Gedik O.

Int Urol Nephrol. 2015 Feb;47(2):353-8. doi: 10.1007/s11255-014-0889-5. Epub 2014 Dec 24.

PMID:
25537827
10.

Evaluating risk of ESRD in the urban poor.

Maziarz M, Black RA, Fong CT, Himmelfarb J, Chertow GM, Hall YN.

J Am Soc Nephrol. 2015 Jun;26(6):1434-42. doi: 10.1681/ASN.2014060546. Epub 2014 Dec 4.

PMID:
25475746
11.

Arterial stiffness and chronic kidney disease: lessons from the Chronic Renal Insufficiency Cohort study.

Townsend RR.

Curr Opin Nephrol Hypertens. 2015 Jan;24(1):47-53. doi: 10.1097/MNH.0000000000000086. Review.

PMID:
25470015
12.

Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).

Grams ME, Li L, Greene TH, Tin A, Sang Y, Kao WH, Lipkowitz MS, Wright JT, Chang AR, Astor BC, Appel LJ.

Am J Kidney Dis. 2015 Mar;65(3):394-402. doi: 10.1053/j.ajkd.2014.07.026. Epub 2014 Oct 14.

PMID:
25441435
13.

Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review.

Greenberg JH, Coca S, Parikh CR.

BMC Nephrol. 2014 Nov 21;15:184. doi: 10.1186/1471-2369-15-184. Review.

14.

Angiotensin blockade in late autosomal dominant polycystic kidney disease.

Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD; HALT-PKD Trial Investigators.

N Engl J Med. 2014 Dec 11;371(24):2267-76. doi: 10.1056/NEJMoa1402686. Epub 2014 Nov 15.

15.

Kidney disease and cognitive function: African American-diabetes heart study MIND.

Palmer ND, Sink KM, Smith SC, Xu J, Bowden DW, Hugenschmidt CE, Whitlow CT, Williamson JD, Maldjian JA, Divers J, Freedman BI.

Am J Nephrol. 2014;40(3):200-7. doi: 10.1159/000367669. Epub 2014 Oct 10.

PMID:
25323981
16.

Erythropoiesis-stimulating agents (ESA) for preventing the progression of chronic kidney disease: a meta-analysis of 19 studies.

Covic A, Nistor I, Donciu MD, Dumea R, Bolignano D, Goldsmith D.

Am J Nephrol. 2014;40(3):263-79. doi: 10.1159/000366025. Epub 2014 Oct 15. Review.

17.

Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.

Elsherbiny HE, Alexander MP, Kremers WK, Park WD, Poggio ED, Prieto M, Lieske JC, Rule AD.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1892-902. doi: 10.2215/CJN.02560314. Epub 2014 Oct 15.

PMID:
25318758
18.

Updating the natural history of diabetic nephropathy.

Pugliese G.

Acta Diabetol. 2014 Dec;51(6):905-15. doi: 10.1007/s00592-014-0650-7. Epub 2014 Oct 9. Review.

PMID:
25297841
19.

CKD and hypertension during long-term follow-up in children and adolescents previously treated with extracorporeal membrane oxygenation.

Zwiers AJ, IJsselstijn H, van Rosmalen J, Gischler SJ, de Wildt SN, Tibboel D, Cransberg K.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2070-8. doi: 10.2215/CJN.02890314. Epub 2014 Oct 2.

PMID:
25278545
20.

Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression.

Faria B, Henriques C, Matos AC, Daha MR, Pestana M, Seelen M.

Clin Exp Immunol. 2015 Feb;179(2):354-61. doi: 10.1111/cei.12461.

PMID:
25267249
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk